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ABSTRACT
Context: Widespread use of myomectomy during caesarean delivery could potentially eliminate multiple surgeries 
for both indications. However, many surgeons have been reluctant to adopt this policy without conclusive evidence 
demonstrating its safety.
Objective: To evaluate the safety of myomectomy during caesarean delivery.
Study Design: A review of the publications on caesarean myomectomy especially from the African continent. 
Main outcome measures: Duration of surgery, blood loss, length of hospital stay and blood transfusions.
Results: Judging from the lack of large studies on caesarean myomectomy, the proportion of surgeons who attempt 
the procedure is low largely because of concerns about its safety. However, most of the authors suggested that the 
complications and morbidity following caesarean myomectomy do not significantly differ from those occurring 
during caesarean section alone, while fertility is apparently not compromised by this treatment. With careful patient 
selection, adequate experience and efficient haemostatic measures, the procedure does not appear as hazardous as 
was once thought. This information is relevant for counseling women who request for the simultaneous removal of 
previously diagnosed fibroids during caesarean section. 
Conclusion: Although complications could occur, caesarean myomectomy appears safe. Staff and facilities for safe 
management of haemorrhage are a requisite for the procedure. Large randomized trials are needed to guide decisions 
as to the best clinical practice regarding myomectomy during caesarean delivery.
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INTRODUCTION
Fibroids, benign tumours of the uterine smooth 
muscle, are commonly found in Negresses, a great 
proportion of who live on the African Continent. 
Although the exact incidence is unknown, they 
generally affect women in the childbearing ages. At 
post-mortem, an incidence of about 50% of women 
has been documented while they have been 
,encountered in 0.3 to 3% of pregnancies.  
These tumours may be asymptomatic. In the 
pregnant women with co-existing fibroids, there is 
an increased incidence of first trimester losses, 
pressure symptoms, pain from red degeneration 
(necrobiosis), torsion of a pedunculated variant, 
mal-presentations, preterm rupture of membranes 
3,and preterm labour  during pregnancy, obstructed 
labour from a cervical or lower segment mass intra-
partum and retained placenta, sub-involution of the 
uterus, postpartum endomyometritis and post-
partum haemorrhage in the immediate post-partum 
3, 5, ,
period.    
Management includes medical and surgical options, 
although the definitive and commonest treatment 
modality is still hysterectomy.  However, in the 
African setting where many women have an 
aversion to sterilizing surgeries and high premium is 
placed on children and childbearing, fertility-
,
preserving options will still be favoured.   
Thus, there exists the possibility of the same woman 
undergoing a myomectomy and later, a caesarean 
section or vice versa. If these two procedures can be 
safely performed at the same time, the risk of 
anaesthetic complications, multiple surgeries, 
adhesions and intra- or postoperative haemorrhage, 
exorbitant costs of operative procedures and 
hospital stay could be reduced. This may provide a 
leeway in the management of this gynaecological 
disorder in the developing nations of Africa, the very 
population in which it is commonest.
This study was thus conducted to examine the 
evidence, if any, for the safety of myomectomy 
during caesarean section.
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MATERIALS AND METHODS
An electronic search of the published literature was 
conducted using the search terms “caesarean 
myomectomy,” “myomectomy during caesarean 
section” and “fibroids and pregnancy.” PubMed and 
other indexed journals in the field of obstetrics and 
gynaecology that specifically addressed fibroids co-
existing with pregnancy were searched. Websites of 
international organizations and private foundations 
with information on the management of pregnant 
women with fibroids were also searched. Original 
and review articles along with case reports that 




Elective myomectomy at the time of caesarean 
section has been traditionally discouraged due to the 
attendant morbidity, primarily from haemorrhage. 
Although there appears to be little direct evidence, 
the removal of intramural myomata from the 
pregnant uterus was regarded as unsafe because of 
the recognized difficulty in controlling blood loss. 
However, two of the earliest works on caesarean 
myomectomy included a report of 13 surgeries with 
successful outcomes (although one patient had 
intra-operative haemorrhage requiring uterine 
artery ligation and blood transfusion) and a review 
of 47 incidental myomectomy cases during 
caesarean section which noted that although the 
procedure added 11minutes to the time for a 
caesarean section, 112mls to the blood loss at 
surgery and half-a-day to the duration of hospital 
stay, there were no wound infections or serious 
morbidity. Both suggested that concomitant 
myomectomy with caesarean section was safe if it 
was done in carefully selected patients.
Subsequent documentation showed that out of a 
small series of 9 patients who underwent elective 
myomectomy at the time of caesarean delivery, 3 
were reportedly complicated by severe 
haemorrhage requiring obstetric hysterectomy, 
while in another report, out of 5 cases, 4 were 
performed on pedunculated fibroids and were 
removed without difficulty, while the only non-
pedunculated fibroid that was removed was 
associated with severe hemorrhage.
In the last decade, there have been various reports 
using several indices to assess the safety or 
otherwise of this procedure. 
Indications
Documented reasons for the removal of uterine 
fibroids during caesarean section include the 
prevention of necrobiosis, pain during pregnancy 
and unusual intra-operative appearance of the 
tumour, to gain access to the baby in patients in 
whom fibroids are obstructing the lower uterine 
segment, pedunculated and anterior uterine 
17, ,
fibroids,    and when the fibroids cause difficulty 
with uterine wound closure thereby causing 
6,
significant blood loss.  
Type of Uterine Incisions
One study included caesarean sections done using 
the lower segment transverse incision in 105 out of 
111 (94.6%) cases and 250 out of 257 (97.3%) 
controls (who had caesarean section without 
myomectomy) while the classical incision was 
17employed in the remainder of the subjects.  An 
Israeli study noted that in four out of 32 cases 
(12.5%), the caesarean sections were classical and 
the reminder done via a lower segment incision. 
However, the myomectomy incisions were 
1, 19generally made on the anterior uterine wall.
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Peri-operative Issues
p-value NS NA NS NS NA
POST-OP 
FEVER







































p-value NS NS NS
Haemostatic Measures
Several recent studies have described techniques 
which can minimize blood loss at caesarean 
myomectomy. These include the application of a 
tourniquet to encompass and compress both uterine 
arteries at the base of the broad ligament and the 
vessels in the infundibulo-pelvic ligament after 
lifting away the Fallopian tubes, thus creating a 
1,
relatively bloodless operating field,   bilateral 
25uterine artery ligation,  electro-cautery, high-dose 
oxytocin infusion during (i.e. after the delivery of 
22, ,
the baby and placenta) and after the surgery    and a 
combination of uterine tourniquet with high-dose 
21oxytocin infusion.
25Sapmaz et al  randomized 52 women with fibroids 
co-existing with pregnancy that had caesarean 
myomectomy into two groups: the first had bilateral 
ascending uterine artery ligation while the second 
had intra-operative tourniquet applied to assist with 
haemostasis. Total intra-operative blood loss, total 
operation duration, number of enucleated myomata 
and febrile morbidity were similar in the 2 groups. 
However, urgent laparotomy and bilateral internal 
iliac artery ligation had to be performed in 1 patient 
in the tourniquet group because of postoperative 
hemorrhage. They concluded that despite the fact 
that bilateral ascending uterine artery ligation and 
tourniquet use had similar outcomes with regard to 
intra-operative blood loss in caesarean 
myomectomy cases, the efficacy of ligation on 
blood loss in the postoperative period continues 
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257 16 94 12 80
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Contr 51 NA 50.83 NA
mls = milliliters; NS = Not Significant (p > 0.05); Hb 
= Haemoglobin concentration; PCV = Packed Cell 
Volume; g/dl = grammes per deciliter; mins = 
minutes; NA = Not Assessed.
When the size of the uterine myomata exceeded 6 
cm, the operation time was observed to be longer in 
the caesarean myomectomy group. Other 
documented peri-operative concerns during 
caesarean myomectomy include post-operative 
anaemia, fractures of the humerus and clavicle in one 
19, 24
baby and puerperal sepsis.  Repeat operations 
following caesarean myomectomy have been 
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documented mostly for excessive bleeding and one 
22for haematoma formation below the scar.  These 
have sometimes resulted in hysterectomy.  
Future Obstetric Performance
In a follow up study of 25 women who had caesarean 
myomectomy in their erstwhile pregnancies, three 
(12%) patients became pregnant, two (66.7%) of 
whom had normal vaginal deliveries, while the third 
24had a repeat elective caesarean section.  A 
prospective non-randomized study was conducted 
by Adesiyun et al to determine the future fertility 
and pregnancy outcomes in 29 pregnant clients who 
had caesarean myomectomy in their last delivery. 
Of these, 22 (75.9%) of the females have had only 
one parous experience and 25 (86.2%) had had one 
previous caesarean section. Only six (20.7%) of 
them had fertility treatment before the attainment of 
the index pregnancy. The common antenatal 
complications recorded were abnormal lie/mal-
presentation (10.3%), placenta praevia (10.3%) and 
threatened abortion (10.3%). They found 17 patients 
eligible for trial of vaginal birth out of which 13 
(44.8%) had successful vaginal births after 
caesarean myomectomy. Of the 16 (55.2%) that had 
repeat caesarean section, 1 also had caesarean 
hysterectomy. There was no maternal or perinatal 
mortality recorded. They concluded that future 
fertility and/or subsequent pregnancy outcome in 
patients is unaffected by caesarean myomectomy. 
DISCUSSION
Fibroids are the commonest tumours in our female 
population in Nigeria. In fact, Agboola reckoned 
that over 80% of women above 25 years have 
fibroids, even if it is just the size of a seedling! 
Hardly is the operation list of a gynaecologist in the 
country complete without the inclusion of a 
myomectomy or hysterectomy for the removal of 
fibroids. Also, fibroid(s) co-existing with and/or 
complicating pregnancy is not an uncommon 
19presentation to Obstetricians practicing in Africa.
Uterine fibroids could become symptomatic and 
then, therapy becomes inevitable. However, in most 
countries on the African continent where fibroids 
are common, the most popular management options 
are 'conventional' myomectomy and hysterectomy. 
This is because the other alternatives available in 
developed nations appear to be more expensive, 
with infrastructural support way beyond the 
capability of many African nations. The 
training/expertise is also not widely available in 
most parts of the continent.
Many African women however, have an aversion for 
surgeries resulting in loss of the womb because of 
the cultural and, at times religious belief of 
reincarnation (without their wombs!) and an 
attachment to preservation of menstruation and 
9, 10childbearing.
Also, caesarean section has become one of the 
commonest hospital-based operative procedures in 
many African nations. For example, in Ghana, the 
1
rate increased from 10% in 1970 to 20% in 1999.  
If myomectomy could be safely done during 
caesarean deliveries, it could prevent the added 
morbidity of a separate procedure (laparotomy to 
remove fibroids, anaesthesia and its possible 
complications) in the future, justifying the cost 
27
effectiveness of the approach.  This would be a 
significant benefit of the procedure in resource-
3
constrained settings.  Puerperal uterine sub-
involution could also be minimized as well as other 
known complications of fibroids such as 
menorrhagia, anaemia and pain (e.g. from torsion or 
1
'red' degeneration during a subsequent pregnancy).  
A retrospective case-controlled study including 
1,242 pregnant women with fibromyomas who 
underwent myomectomy during caesarean section 
and three control groups of 200 matched pregnant 
women without fibromyomas who underwent 
caesarean deliveries (Group A), 145 patients with 
fibromyomas who underwent caesarean deliveries 
without removal of fibromyomas (Group B) and 51 
patients with fibromyomas who had a hysterectomy 
during caesarean section found no differences in the 
mean hemoglobin change, the incidence of 
postoperative fever and the length of hospital stay 
among all the groups. Also, since fibroids are 
sometimes located in the lower uterine segment, 
their non-removal will only leave the surgeon with 
one alternative: a 'classical' incision on the uterus 
with all its attendant complications.  
Apart from the above stated advantages of caesarean 
myomectomy, another benefit is that it increases the 
chances of vaginal delivery in subsequent 
pregnancies when removed from the lower uterine 
segment. The scar integrity following caesarean 
myomectomy has been shown to be better than that 
following interval myomectomy,  when assessed 
with serial ultrasound scan in subsequent 
36 37
pregnancies  and at subsequent caesarean section.
The results from the reviewed studies indicate that 
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caesarean myomectomy is safe and offers no 
significantly increased risks to the patient than 
caesarean section alone. These surgeries have been 
largely performed on pedunculated and anterior 
fibroids individually less than 6cm, and those 
obstructing the lower uterine segment or wound 
closure after extraction of the baby. However, if it is 
performed as an emergency procedure when the 
patient is already in labour or has ruptured the fetal 
membranes, there is an increased risk of sepsis 
19occurring.   
The problem of haemorrhage with the need for 
blood transfusion, especially in our environment 
where unsafe blood transfusion due to transmission 
of Human Immunodeficiency Virus (HIV) and 
serum Hepatitides still occurs, is also of paramount 
concern. Improving the outcome of this procedure 
would also require improved blood banking 
services.
CONCLUSION
The possibility of safely performing myomectomy 
during caesarean section is appealing in the low-
resource settings of sub-Saharan Africa where 
fibroids are common. 
The decision to proceed with elective myomectomy 
at the time of caesarean delivery should be 
approached with caution, and should perhaps be 
limited only to patients with pedunculated fibroids 
or to instances in which the lower segment incision 
(for extracting the baby) cannot be closed without 
removal of the fibroid(s). Centres in which 
caesarean myomectomy will occur routinely must 
of necessity have adequately staffed and equipped 
blood banks whose practices meet international 
standards.
It is recommended that large multi-centre 
randomized trials be conducted to evaluate the best 
practice for myomectomy at caesarean section. 
These will identify appropriate selection criteria, 
surgical techniques, haemostatic options and 
improve the overall outcome of the procedure. 
Meta-analyses should be done to assess whether 
other haemostatic options employed on non-gravid 
uteri e.g. vaginal misoprostol, bupivacaine-
epinephrine injection, enucleation of the myomata 
by morcellation may be effective during caesarean 
myomectomy. Longitudinal studies to evaluate the 
long-term obstetric consequences and the risk of 
uterine rupture in subsequent pregnancies are also 
needed.
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